PIC/S adopts technical interpretation of revised GMP requirements for sterile products
This article was originally published in SRA
Executive Summary
The committee of the international Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) has adopted a long-awaited technical interpretation of the revised good manufacturing practice requirements for sterile medicinal products, which came into effect earlier this year1,2.